Boston and Medtronic settle stent litigation
This article was originally published in Clinica
Executive Summary
Boston Scientific and Medtronic have settled three patent lawsuits. The lawsuits related to Boston's Keith patents and Medtronic Enger patents, which cover coronary stent delivery systems and rapid exchange balloon dilatation catheters. Terms of the agreement were not disclosed.